Serum soluble CD27 level is associated with outcome in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (Q83331907)
Jump to navigation
Jump to search
scientific article published on 01 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum soluble CD27 level is associated with outcome in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone |
scientific article published on 01 March 2012 |
Statements
Serum soluble CD27 level is associated with outcome in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (English)
Naoe Goto
Hisashi Tsurumi
Masao Takemura
Nobuhiro Kanemura
Senji Kasahara
Takeshi Hara
Ichiro Yasuda
Masahito Shimizu
Toshiki Yamada
Michio Sawada
Takeshi Takahashi
Tetsuya Yamada
Mitsuru Seishima
Hisataka Moriwaki
Tsuyoshi Takami